𝔖 Bobbio Scriptorium
✦   LIBER   ✦

[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer

✍ Scribed by D. Vallböhmer; A.H. Hölscher; P.M. Schneider; M. Schmidt; M. Dietlein; E. Bollschweiler; S. Baldus; H. Alakus; J. Brabender; R. Metzger; S. P. Mönig

Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
191 KB
Volume
102
Category
Article
ISSN
0022-4790

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Evaluation of chemotherapy response in p
Evaluation of chemotherapy response in patients with advanced head and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography
✍ Val J. Lowe; Frank R. Dunphy; Mark Varvares; Han Kim; Mark Wittry; Cherie H. Dun 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 186 KB 👁 2 views

## Background: [f-18]fluorodeoxyglucose (fdg)-positron emission tomography (pet) can measure the metabolic activity of tissues; fdg-pet may be able to predict response to chemotherapy by identifying changes in tumor metabolism. measurement of response to treatment may help improve survival in the m

Monitoring of early response to neoadjuv
Monitoring of early response to neoadjuvant chemotherapy in breast cancer with 1H MR spectroscopy: Comparison to sequential 2-[18F]-fluorodeoxyglucose positron emission tomography
✍ Mitsuhiro Tozaki; Masaaki Sakamoto; Yu Oyama; Toshihiro O'uchi; Naoko Kawano; Ta 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 310 KB

## Abstract ## Purpose To assess the efficacy of ^1^H MR spectroscopy (MRS) to evaluate early responses to neoadjuvant chemotherapy in breast cancer patients, as compared to that of the standardized uptake value (SUV) in ^18^F‐fluorodeoxyglucose (FDG) positron emission tomography (PET). ## Materi

Prospective comparison of [18F]fluorodeo
Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma
✍ Christian Kollmannsberger; Karin Oechsle; Bernhard M. Dohmen; Anna Pfannenberg; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB 👁 1 views

## Abstract ## BACKGROUND To assess the ability of [^18^F]fluorodeoxyglucose (F‐18 FDG) positron emission tomography (PET) to predict the viability of residual masses after chemotherapy in patients with metastatic nonseminomatous germ cell tumors (GCT), PET results were compared in a blinded analy